---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-043862"
form_type: "8-K"
ticker: "HRGN"
cik: "0001563665"
company_name: "Harvard Apparatus Regenerative Technology, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:32:35.452198+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Harvard Apparatus Regenerative Technology signs exclusive global distribution deal with Health Regen through 2030

## Summary
- Exclusive distribution of consumer health/dietary supplements from Nov 1, 2024 to Dec 31, 2030; auto-renews for 6 years if targets met.
- Annual sales targets: $1M (2025) escalating to $20M (2030); Company receives 10% markup on manufacturing costs plus pass-through costs.
- Early termination by Company triggers penalty of 3x projected annual sales in year 6.
- Chinese subsidiary employees and inventory to be transferred to Health Regen effective Nov 1, 2024.

## SEC filing metadata
- accession: 0001493152-24-043862
- form_type: 8-K
- ticker: HRGN
- cik: 0001563665
- company_name: Harvard Apparatus Regenerative Technology, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563665/000149315224043862/0001493152-24-043862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563665/000149315224043862/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-043862
- JSON: https://secwatch.observer/filing/0001493152-24-043862.json
- Plain text: https://secwatch.observer/filing/0001493152-24-043862.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.